Clinical trials: Repository Corticotropin Injection
Rheumatoid Arthritis
Repository Corticotropin Injection To Treat Rheumatoid Arthritis Patients Who Have Failed Three Biologic Therapies.
It is hypothesized that repository corticotropin injection in combination with other biologic agents will be able to provide relief of both rheumatoid arthritis and acute exacerbations of rheumatoid arthritis for patients with…
- Trial name
- NCT01966718
- Testing
- Repository corticotropin injection
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- Arthritis Treatment Center, Maryland